These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33154509)

  • 21. Cardiomyocyte functional screening: interrogating comparative electrophysiology of high-throughput model cell systems.
    Wells SP; Waddell HM; Sim CB; Lim SY; Bernasochi GB; Pavlovic D; Kirchhof P; Porrello ER; Delbridge LMD; Bell JR
    Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1256-C1267. PubMed ID: 31577512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
    Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior.
    Mandel Y; Weissman A; Schick R; Barad L; Novak A; Meiry G; Goldberg S; Lorber A; Rosen MR; Itskovitz-Eldor J; Binah O
    Circulation; 2012 Feb; 125(7):883-93. PubMed ID: 22261196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Scalable Approach Reveals Functional Responses of iPSC Cardiomyocyte 3D Spheroids.
    Burnham MP; Harvey R; Sargeant R; Fertig N; Haddrick M
    SLAS Discov; 2021 Mar; 26(3):352-363. PubMed ID: 33283596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers.
    Xue T; Cho HC; Akar FG; Tsang SY; Jones SP; Marbán E; Tomaselli GF; Li RA
    Circulation; 2005 Jan; 111(1):11-20. PubMed ID: 15611367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced pluripotent stem cell derived cardiac models: effects of Thymosin β4.
    Ziegler T; Hinkel R; Kupatt C
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):111-120. PubMed ID: 30063852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Video evaluation of the kinematics and dynamics of the beating cardiac syncytium: an alternative to the Langendorff method.
    Fassina L; Di Grazia A; Naro F; Monaco L; De Angelis MG; Magenes G
    Int J Artif Organs; 2011 Jul; 34(7):546-58. PubMed ID: 21786253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes.
    Chun YW; Balikov DA; Feaster TK; Williams CH; Sheng CC; Lee JB; Boire TC; Neely MD; Bellan LM; Ess KC; Bowman AB; Sung HJ; Hong CC
    Biomaterials; 2015 Oct; 67():52-64. PubMed ID: 26204225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes.
    Lee JJ; Cheng SJ; Huang CY; Chen CY; Feng L; Hwang DY; Kamp TJ; Chen HC; Hsieh PCH
    EBioMedicine; 2019 Feb; 40():675-684. PubMed ID: 30639418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling of functional murine embryonic stem cell-derived cardiomyocytes and comparison with adult heart: profiling of murine ESC-derived cardiomyocytes.
    Shinozawa T; Tsuji A; Imahashi K; Nakashima K; Sawada H; Toyoshiba H; Yamamoto S; Takami K; Imai R
    J Biomol Screen; 2009 Mar; 14(3):239-45. PubMed ID: 19211779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes.
    Beauchamp P; Moritz W; Kelm JM; Ullrich ND; Agarkova I; Anson BD; Suter TM; Zuppinger C
    Tissue Eng Part C Methods; 2015 Aug; 21(8):852-61. PubMed ID: 25654582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.
    Broughton KM; Li J; Sarmah E; Warren CM; Lin YH; Henze MP; Sanchez-Freire V; Solaro RJ; Russell B
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H107-17. PubMed ID: 27199119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.
    Hallas T; Eisen B; Shemer Y; Ben Jehuda R; Mekies LN; Naor S; Schick R; Eliyahu S; Reiter I; Vlodavsky E; Katz YS; Õunap K; Lorber A; Rodenburg R; Mandel H; Gherghiceanu M; Binah O
    J Cell Mol Med; 2018 Feb; 22(2):913-925. PubMed ID: 29193756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arrhythmogenicity Test Based on a Human-Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocyte Layer.
    Slotvitsky M; Tsvelaya V; Frolova S; Dementyeva E; Agladze K
    Toxicol Sci; 2019 Mar; 168(1):70-77. PubMed ID: 30388253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells.
    Kikuchi C; Bienengraeber M; Canfield S; Koopmeiner A; Schäfer R; Bosnjak ZJ; Bai X
    Cell Transplant; 2015; 24(12):2491-504. PubMed ID: 25562386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction.
    Ong SG; Huber BC; Lee WH; Kodo K; Ebert AD; Ma Y; Nguyen PK; Diecke S; Chen WY; Wu JC
    Circulation; 2015 Aug; 132(8):762-771. PubMed ID: 26304668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microdevice Platform for Continuous Measurement of Contractility, Beating Rate, and Beating Rhythm of Human-Induced Pluripotent Stem Cell-Cardiomyocytes inside a Controlled Incubator Environment.
    Wang L; Dou W; Malhi M; Zhu M; Liu H; Plakhotnik J; Xu Z; Zhao Q; Chen J; Chen S; Hamilton R; Simmons CA; Maynes JT; Sun Y
    ACS Appl Mater Interfaces; 2018 Jun; 10(25):21173-21183. PubMed ID: 29874032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. I-Wire Heart-on-a-Chip I: Three-dimensional cardiac tissue constructs for physiology and pharmacology.
    Sidorov VY; Samson PC; Sidorova TN; Davidson JM; Lim CC; Wikswo JP
    Acta Biomater; 2017 Jan; 48():68-78. PubMed ID: 27818308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts.
    Guo L; Qian JY; Abrams R; Tang HM; Weiser T; Sanders MJ; Kolaja KL
    Cell Physiol Biochem; 2011; 27(5):453-62. PubMed ID: 21691062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.